| Literature DB >> 15710594 |
Vincent Lévy, Pierre Morel, Raphaël Porcher, Sylvie Chevret, Eric Wattel, Véronique Leblond.
Abstract
New treatments for patients with Waldenstrom's macroglobulinemia (WM) have necessited the development of prognostic indices. Using a sample of 92 patients with refractory or relapsing WM treated in a randomized trial, we show that Morel's prognostic scoring system for patients at diagnosis is also effective in patients with advanced disease.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15710594
Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941